Symptoms usually come on suddenly, according to the CDC, and can include fevers above 100.4 degrees F, dry cough, sore throat ...

One of the challenges faced when developing influenza virus vaccines is the problem of how to protect populations in the face of spreading pandemics. With the advent of air travel, this readily ...

Seasonal influenza vaccines triggered protective immune responses against the H5N1 avian influenza virus primarily in younger ...

Avian flu is rampant in poultry farms and in wild birds in the U.S. Every mutation brings the virus one step closer to the ...

The H5N1 virus has a ways to go before it can successfully jump to humans but that it doesn’t reduce the threat it poses.

The following is a summary of “Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study,” published in the January 2025 issue of Infectious Disease by ...

Recent history makes clear that microbiological disasters can strike anytime. But a longer history should remind us of the ...

Staying a step ahead of the avian influenza virus with surveillance, testing and research could mean the difference between a ...

F lu season is upon us and it's not just restricted to humans. Highly pathogenic avian influenza (HPAI), also known as avian ...

The NA-Star influenza neuraminidase inhibitor resistance detection kit was used to test for susceptibility to oseltamivir and zanamivir. Influenza A(H5N1) virus was cultured from respiratory ...